tiprankstipranks
Trending News
More News >
Flotek (FTK)
NYSE:FTK
US Market

Flotek (FTK) AI Stock Analysis

Compare
276 Followers

Top Page

FTK

Flotek

(NYSE:FTK)

Select Model
Select Model
Select Model
Outperform 71 (OpenAI - 5.2)
Rating:71Outperform
Price Target:
$19.00
▲(3.49% Upside)
Action:UpgradedDate:03/12/26
The score is driven primarily by improved financial fundamentals (profitability recovery and sharply reduced leverage) and a strong earnings-call outlook led by fast-growing, high-margin Data Analytics and expected PowerTech growth. Offsetting factors are weaker cash conversion versus earnings, only moderate technical momentum, and a valuation profile that lacks dividend support.
Positive Factors
High‑margin Data Analytics growth
Flotek's Data Analytics business has shifted the revenue mix toward recurring, high‑margin services, evidenced by very high gross margins and sizable recurring revenue. This creates durable margin expansion, predictable cash flow streams, and a moat via analytics expertise and patents that support long‑term profitability.
De‑risked balance sheet
Substantially reduced leverage and a stronger equity base materially improve financial flexibility. Low absolute debt and a larger asset base support capital allocation for growth initiatives, capacity investments and potential M&A while lowering insolvency risk through industry cycles.
PowerTech integration and new market entry
Integration of PowerTech creates a durable second leg of higher‑margin services and expands addressable markets (utilities, disaster recovery). Fleet growth and contract wins convert into recurring service revenue and operational scale benefits, diversifying Flotek's exposure beyond chemistry sales.
Negative Factors
Weak cash conversion
Earnings have not consistently converted into cash, leaving free cash flow fragile relative to reported profits. This structural cash conversion gap increases reliance on credit lines for CapEx and fleet expansion and raises risk that profitability improvements may not sustainably fund growth or reduce leverage.
Choppy revenue and margin consistency
Historic volatility in revenue and margins undermines predictability of earnings and makes long‑term planning harder. Cyclical end markets and product‑mix swings can produce earnings volatility, limiting confidence that recent margin gains are fully durable across cycles.
Rising capital intensity and execution risk
A step‑up in CapEx and rapid fleet expansion increases funding needs and execution demands. If cash conversion remains weak, higher capital intensity could pressure liquidity, delay returns on investment, and amplify operational risks tied to scaling field operations and service delivery.

Flotek (FTK) vs. SPDR S&P 500 ETF (SPY)

Flotek Business Overview & Revenue Model

Company DescriptionFlotek Industries, Inc. operates as a technology-driven chemistry and data company that serves customers across industrial, commercial, and consumer markets in the United States, the United Arab Emirates, and internationally. It operates in two segments, Chemistry Technologies (CT) and Data Analytics (DA). The CT segment designs, develops, manufactures, packages, distributes, delivers, and markets green specialty chemicals that enhance the profitability of hydrocarbon producers and cleans surfaces in commercial and personal settings to help reduce the spread of bacteria, viruses, and germs. This segment primarily serves integrated oil and gas, oilfield services, independent oil and gas, national and state-owned oil, geothermal energy, solar energy, and alternative energy companies. The DA segment designs, develops, produces, sells, and supports equipment and services that create and provide valuable information on the composition and properties of energy customers' hydrocarbon fluids. This segment's data platforms combine the energy industry's field-deployable, inline optical analyzer with proprietary cloud visualization and analytics. It sells its products directly through a mix of in-house sales professionals, as well as contractual agency agreements. The company was incorporated in 1985 and is headquartered in Houston, Texas.
How the Company Makes MoneyFlotek generates revenue primarily through the sale of its specialty chemicals and related services to oil and gas companies. The company has a diversified revenue model that includes direct sales of its chemical products, which are used in various applications such as drilling fluids, completion fluids, and enhanced oil recovery. Additionally, Flotek earns income through service contracts that involve the application of its products in the field, thereby providing technical support and expertise. Strategic partnerships with major oil and gas operators further enhance their market reach and revenue potential, allowing for collaborative projects that can lead to increased sales of their chemical solutions. The company may also benefit from pricing strategies that reflect the demand for more environmentally friendly and efficient products, positioning themselves competitively within the energy sector.

Flotek Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Chart Insights
Data provided by:The Fly

Flotek Earnings Call Summary

Earnings Call Date:Mar 11, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 12, 2026
Earnings Call Sentiment Positive
The call presented strong, company-wide positive momentum driven by exceptional Data Analytics growth, meaningful upstream revenue and gross profit expansion, successful PowerTech integration, a major measurement milestone (XBEG GPA 2172 qualification), and materially improved adjusted EBITDA and recurring revenue. These positives materially outweigh several near-term headwinds including a Q4 dip in external chemistry revenue, one-time penalty impacts, Q4 EPS pressure from higher depreciation/interest and a temporary spike in the effective tax rate, and manageable supply-chain/geopolitical risks. Management provided clear forward levers (PowerTech revenue ramp, backlog, CapEx plans, and expected tax normalization) that support continued upside into 2026.
Q4-2025 Updates
Positive Updates
Record Revenue and Historical Highs
Highest quarterly and annual revenues since 2017; Data Analytics segment achieved its highest-ever quarterly and annual revenue in company history; total company revenue grew 33% YoY in the fourth quarter.
Data Analytics Explosive Growth and Profitability
Data Analytics service revenues surged (management cited +381% versus the comparable period) and DA gross profit reached 73% in Q4 2025 versus 39% a year ago; DA gross profit contributed 48% of total company gross profit in 2025 compared with 8% in the year-ago quarter.
Large Increase in Upstream Revenues and Gross Profit
Upstream revenues expanded from $2.1 million in 2024 to over $21 million in 2025; upstream gross profit rose from $1.2 million in 2024 to $18.4 million in 2025, indicating material margin expansion in upstream analytics.
Adjusted EBITDA and Net Income Improvement
Adjusted EBITDA grew 123% year-over-year for the full year (40% growth in the quarter under the revised calculation); management indicates adjusted EBITDA near the top of original guidance. Full-year net income improved substantially (management cited a 191% improvement for 2025).
Recurring Revenue and Backlog Momentum
Exited the year with over $12.02 million per month in recurring high-margin revenue from Data Analytics deployments and a multiyear backlog providing visibility to future cash flows and margin expansion.
PowerTech Integration and Revenue Catalyst
Completed onboarding of PowerTech assets; PowerTech generated $15.8 million of revenue in 2025 and is expected to generate north of $27 million in 2026 (approximately +70% year-over-year), with the utility/disaster recovery contract incremental to that run rate.
Technology and Measurement Milestone (XBEG)
XBEG spectrometer became the first optical instrument to meet GPA 2172 custody-transfer reproducibility and repeatability requirements (10/29/2025), providing a key competitive and commercial advantage for custody-transfer and digital valuation use cases.
Chemistry Segment Resilience
Chemistry Technology revenues increased ~25% for full year 2025 versus 2024 (excluding OSP payment), despite a 24% decline in average North American frac fleet count (201 to 154) over the same period — demonstrating resilience and market share gains.
Safety and Operational Excellence
Achieved zero lost time incidents in field operations for the year; Prescriptive Chemistry Management and Raceland NTI team surpassed 10 years without a lost time incident.
Balance Sheet and Deferred Tax Recognition
Total assets rose to just over $220 million after release of valuation allowance (allowing deferred tax asset recognition); company ended the year with $5.7 million cash and $3.3 million drawn on ABL, and management expects non-cash tax adjustments to normalize forward.
Negative Updates
Quarterly Chemistry Revenue Weakness
External customer Chemistry revenue declined ~30% from the year-ago quarter (Q4) due largely to slowing activity in November and December, although full-year external Chemistry revenues were still up ~26% versus 2024.
Quarterly Net Income and EPS Pressure
Q4 net income was $3.0 million ($0.08 diluted EPS) versus $4.4 million ($0.14) in the year-ago quarter — a quarter-to-quarter decline influenced by higher depreciation and interest related to the PowerTech acquisition and a higher effective tax rate in the quarter.
Spike in Effective Tax Rate
Effective tax rate in Q4 was ~35% versus 7% in the prior-year period due to non-cash adjustments tied to valuation allowance changes; management expects normalization closer to ~21% going forward but Q4 was a tax headwind to EPS.
Increased SG&A and Non-Recurring Costs
SG&A increased versus the prior-year quarter driven by higher personnel costs (including stock compensation) and elevated professional fees (including integrated audit costs); although SG&A as a percent of revenue improved to 11% from 13%, absolute operating costs were higher.
Product-Mix and One-Time Penalty Impact on Gross Margin
Q4 gross profit margin (22.5% of revenue) was impacted by product mix and approximately $5 million sequential reduction related to a shortfall penalty associated with a large ProFrac quarter, pressuring margins in Q4.
International Supply-Chain and Geopolitical Risks
Ongoing conflicts (Middle East/Houthi-related shipping disruptions) have strained certain specialty chemical supply routes, potentially increasing shipping costs and requiring alternative (more expensive) delivery methods; management notes this is being actively managed but remains a risk.
Company Guidance
The company reiterated forward-looking financial and operational targets: adjusted EBITDA grew 123% for full-year 2025 (up ~40% in Q4) and, using the prior methodology, would be roughly $10.1 million, with management saying adjusted EBITDA is near the top end of its guidance range; PowerTech contributed $15.8 million in 2025 and is expected to be north of $27 million in 2026 (≈70% year-over-year increase) and remain a major driver of 2026 results; Data Analytics posted about $18 million of gross profit in 2025, accounted for 48% of company gross profit (vs 8% a year ago), exited the year with >$12.02 million per month of recurring revenue and 35+ patents, and is expected to exceed 50% of company profitability in 2026; total company revenue growth was 33% in the quarter, Q4 gross profit margin was 22.5%, gross profit rose ~24% versus the prior-year quarter and ~52% for the full year, Q4 net income was $3.0 million ($0.08/share) versus $4.4 million ($0.14) a year ago, the Q4 effective tax rate was ~35% but is expected to normalize toward ~21% (with little to no cash taxes anticipated beyond state taxes), year-end cash was $5.7 million with $3.3 million drawn on the ABL and total assets ~ $220 million, CapEx is expected to rise to roughly $10–$15 million in 2026 (vs ~$2 million in 2025), the PowerTech fleet stands at ~30 units (15 pairs) with a goal to double by year-end, and upstream revenues jumped from $2.1 million in 2024 to >$21 million in 2025 (upstream gross profit from $1.2 million to $18.4 million).

Flotek Financial Statement Overview

Summary
Turnaround is evident with solid recent profitability and improved margins, plus a substantially de-risked balance sheet (very low leverage). The main offset is cash-flow quality: operating cash flow and free cash flow are positive but remain low versus net income and volatile.
Income Statement
72
Positive
Profitability has improved meaningfully versus earlier loss years (2020–2022), with the company now generating solid positive net margins in 2023 (13.1%) and 2025 (12.9%). Gross margin also recovered from negative levels in 2022 to ~25.2% in 2025, showing better pricing and/or cost control. Revenue growth is positive in 2025 (+7.6%), but the top line has been choppy across years (flat in 2024, strong rebound in 2022–2023), which tempers confidence in durability. Margin metrics also show some inconsistency (e.g., strong 2023 operating profitability vs lower EBITDA margin in 2025), indicating earnings quality may be volatile.
Balance Sheet
80
Positive
Leverage has been substantially de-risked: debt-to-equity improved from extremely high levels in 2022 (46.1x, driven by very low equity) to very conservative levels by 2025 (~0.06x), and total debt has declined to ~$7.2M. Equity has stabilized around ~$113M in 2024–2025 and the asset base has expanded (to ~$220M in 2025), supporting financial flexibility. Returns on equity are strong in 2023–2025 (24.2% and 27.0%), though the historical drawdown and negative equity profitability in 2020–2022 highlight that the balance sheet has been through a stressed period and could be sensitive if operating conditions weaken.
Cash Flow
58
Neutral
Cash generation has improved from materially negative operating and free cash flow in 2020–2023 to positive in 2024–2025 (operating cash flow ~$3.4M to ~$7.2M; free cash flow ~$1.4M to ~$5.2M). However, cash conversion remains a key watch item: in 2024 and 2025, operating cash flow is low relative to net income (coverage ~0.07x and ~0.12x), suggesting earnings are not translating into cash as efficiently as desired. Free cash flow growth is also volatile (sharp decline indicated in 2025), reinforcing that cash flow stability is still developing.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Mar 2022
Income Statement
Total Revenue237.26M187.03M188.06M136.09M43.27M
Gross Profit59.83M39.39M24.26M-6.70M3.26M
EBITDA36.27M13.13M28.45M-34.54M-29.48M
Net Income30.53M10.50M24.71M-42.30M-30.53M
Balance Sheet
Total Assets220.05M170.80M157.51M164.81M50.24M
Cash, Cash Equivalents and Short-Term Investments5.73M4.40M5.85M12.29M11.53M
Total Debt7.24M12.85M17.88M119.58M13.26M
Total Liabilities106.99M56.90M55.55M162.21M30.05M
Stockholders Equity113.06M113.90M101.96M2.60M20.19M
Cash Flow
Free Cash Flow5.22M1.42M-12.38M-45.05M-25.88M
Operating Cash Flow7.20M3.36M-11.30M-44.63M-25.84M
Investing Cash Flow-1.98M-1.82M-1.01M5.33M112.00K
Financing Cash Flow-3.74M-3.12M5.93M38.27M-372.00K

Flotek Technical Analysis

Technical Analysis Sentiment
Positive
Last Price18.36
Price Trends
50DMA
17.21
Positive
100DMA
16.52
Positive
200DMA
15.05
Positive
Market Momentum
MACD
0.13
Negative
RSI
60.82
Neutral
STOCH
82.20
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FTK, the sentiment is Positive. The current price of 18.36 is above the 20-day moving average (MA) of 16.80, above the 50-day MA of 17.21, and above the 200-day MA of 15.05, indicating a bullish trend. The MACD of 0.13 indicates Negative momentum. The RSI at 60.82 is Neutral, neither overbought nor oversold. The STOCH value of 82.20 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FTK.

Flotek Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$454.62M15.187.10%0.63%9.53%15.48%
71
Outperform
$551.86M19.1329.42%23.56%242.78%
68
Neutral
$619.31M-45.45-3.11%-1.29%-123.25%
68
Neutral
$396.82M24.425.54%1.71%-5.47%2.24%
66
Neutral
$727.29M-3.63-16.46%-11.02%
65
Neutral
$15.17B7.614.09%5.20%3.87%-62.32%
47
Neutral
$155.69M-5.56-21.91%-18.29%-43.05%
* Energy Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FTK
Flotek
18.36
9.48
106.76%
FET
Forum Energy Tech
55.02
37.27
209.97%
NGS
Natural Gas Services Group
36.17
14.22
64.75%
OIS
Oil States International
12.08
7.19
147.03%
GEOS
Geospace Technologies
12.08
4.72
64.13%
RNGR
Ranger Energy Services
16.85
3.17
23.14%

Flotek Corporate Events

Business Operations and StrategyFinancial DisclosuresRegulatory Filings and Compliance
Flotek Posts Record 2025 Results Led by Data Analytics
Positive
Mar 12, 2026

Flotek reported that for the fourth quarter and full year ended December 31, 2025, it delivered its highest quarterly and annual revenues since 2017, with total revenue up 33% in the quarter and 27% for the year, and gross profit up 24% and 52%, respectively, versus 2024. Full-year net income climbed 191% to $30.5 million, while revised-methodology Adjusted EBITDA more than doubled to $32.8 million, driven largely by rapid growth in its Data Analytics segment and contributions from its April 2025 entry into power services.

Data Analytics achieved record quarterly and annual revenue and accounted for 48% of companywide gross profit in the fourth quarter of 2025, sharply higher than 8% a year earlier, underscoring a shift toward higher-value, tech-enabled services. Flotek also changed its Adjusted EBITDA calculation to stop adding back non-cash amortization of contract assets under SEC guidance, which lowers the comparable guidance range but does not affect operating cash flow or debt covenants, clarifying earnings quality for investors and other stakeholders.

The most recent analyst rating on (FTK) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Flotek stock, see the FTK Stock Forecast page.

Business Operations and Strategy
Flotek Wins First Utilities Infrastructure Contract with PWRtek
Positive
Mar 3, 2026

On March 3, 2026, Flotek Industries announced its first contract in the utilities infrastructure sector, using its proprietary PWRtek platform to coordinate the installation of up to 50 megawatts of natural gas power generation, advanced gas distribution, and smart conditioning systems. The six-month contract, tied to federal disaster recovery efforts in a wind-damaged area, could generate about $1 million per megawatt if fully utilized and marks a strategic expansion into emergency and infrastructure power markets, underscoring rising demand for its real-time data and chemistry-based power technologies.

Under the agreement, Flotek will deploy smart conditioning skids and gas distribution equipment designed to optimize fuel delivery, improve uptime, and enable maintenance without interrupting electricity supply, supporting a new residential development and critical local infrastructure. The staged rollout over several weeks is expected to enhance the company’s positioning as a provider of high-reliability utilities support solutions, potentially diversifying its revenue base and strengthening its role in disaster recovery power services.

The most recent analyst rating on (FTK) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on Flotek stock, see the FTK Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Flotek Appoints Christina Ibrahim as Senior Legal Executive
Positive
Mar 2, 2026

On March 2, 2026, Flotek Industries, Inc. announced the appointment of Christina M. Ibrahim as Senior Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary, with the appointment effective the same day. The move adds a seasoned legal and compliance executive to Flotek’s leadership bench at a time the company frames as a pivotal period of opportunity.

Ibrahim brings extensive experience from senior roles at Select Water Solutions, Avalon Advisors, Weatherford International and Halliburton, spanning legal, compliance and operational leadership across energy and wealth management. Her background in guiding complex, global organizations through regulatory and strategic challenges is expected to support Flotek’s growth strategy around innovative chemistry and data solutions, potentially strengthening its governance, risk management and market expansion efforts for investors and other stakeholders.

The most recent analyst rating on (FTK) stock is a Buy with a $19.50 price target. To see the full list of analyst forecasts on Flotek stock, see the FTK Stock Forecast page.

Executive/Board Changes
Flotek Enhances Executive Pay with New Performance-Based Equity
Positive
Feb 25, 2026

On February 24, 2026, Flotek’s board compensation committee approved new equity awards for CEO Dr. Ryan Ezell and CFO J. Bond Clement, consisting of time-based restricted stock units and performance-based restricted stock units. The RSUs vest in three equal annual installments, while the PRSUs are tied to achieving earnings and relative total shareholder return targets over performance periods running from January 1, 2026 through December 31, 2028, reinforcing long-term alignment between executive pay, operational results, and shareholder value.

The awards grant Dr. Ezell 36,595 RSUs and 36,595 PRSUs and grant Mr. Clement 16,635 RSUs and 16,635 PRSUs, all under Flotek’s 2018 Long-Term Incentive Plan. By linking a significant portion of executive compensation to EBITDA metrics and performance versus the Russell 2000 Oil Equipment and Services index, the company is emphasizing sustained profitability and competitive market positioning, which may influence management priorities and risk-taking on behalf of investors.

The most recent analyst rating on (FTK) stock is a Buy with a $19.50 price target. To see the full list of analyst forecasts on Flotek stock, see the FTK Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 12, 2026